Laurion Capital Management LP Iovance Biotherapeutics, Inc. Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $2.1 Million - $5.67 Million	637,742 New	637,742 $5.18 Million
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $143,920 - $413,488	-22,558 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $279,268 - $430,857	22,558 New	22,558 $376,000
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $1.37 Million - $1.8 Million	-49,495 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $976,702 - $1.47 Million	35,895 Added 263.93%	49,495 $1.36 Million
Q1 2020 May 14, 2020	BUY	$19.54 - $38.85 $265,744 - $528,360	13,600 New	13,600 $407,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.